Need professional-grade analysis? Visit stockanalysis.com
$140.61M
3.00
1,202
N/A
Price Chart
Risk-Adjusted Performance
Global Cord Blood Corp (CORBF) Price Performance
Global Cord Blood Corp (CORBF) trades on United States in USD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at $0.95.
Over the past year, CORBF has traded between a low of $0.20 and a high of $1.75. It is currently 45.7% below its 52-week high.
Global Cord Blood Corp has a market capitalization of $140.61M, with a price-to-earnings ratio of 3.00.
About Global Cord Blood Corp
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.
Compare Global Cord Blood Corp
Side-by-side comparison against top Healthcare peers.
Company Info
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- $1.24B
- EBITDA
- $656.79M
- Profit Margin
- 40.30%
- EPS (TTM)
- 0.35
- Book Value
- 5.82
Technical Indicators
- 52 Week High
- $1.75
- 52 Week Low
- $0.20
- 50 Day MA
- $0.96
- 200 Day MA
- $0.95
- Beta
- -0.70
Valuation
- Trailing P/E
- 3.00
- Forward P/E
- N/A
- Price/Sales
- 0.11
- Price/Book
- 0.24
- Enterprise Value
- $-721,783,768